YDES
YD Bio Ltd
NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY
$5.11
-1.53% today
Updated 2026-04-30
Market cap
$385.05M
P/E ratio
—
P/S ratio
754.46x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$5 – $25
Volume
0.0M
YD Bio Ltd (YDES) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $350131.00 | $510360.00 |
| Revenue growth (YoY) | — | — | — | — | +45.8% |
| Cost of revenue | — | — | — | $196686.00 | $355004.00 |
| Gross profit | — | — | — | $153445.00 | $155356.00 |
| Gross margin | — | — | — | 43.8% | 30.4% |
| R&D | — | — | — | $0.00 | $491353.00 |
| SG&A | — | — | — | $153069.00 | $1.12M |
| Operating income | $-344223.00 | $-1.72M | $-2.32M | $-9847.00 | $-1.46M |
| Operating margin | — | — | — | -2.8% | -286.5% |
| EBITDA | $-2.54M | $8.70M | $3.79M | $22246.00 | $-1.28M |
| EBITDA margin | — | — | — | 6.4% | -251.0% |
| EBIT | — | — | — | $19794.00 | $-1.39M |
| Interest expense | — | — | — | $2144.00 | $772.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.54M | $8.70M | $3.79M | $13560.00 | $-1.41M |
| Net income growth (YoY) | — | +443.0% | -56.5% | -99.6% | -10509.7% |
| Profit margin | — | — | — | 3.9% | -276.6% |